Patents Assigned to APOGLYX AB
  • Compounds for modulating aquaporins
    Patent number: 10730865
    Abstract: The invention relates to compounds of formula (I) pharmaceutical compositions thereof and methods for modulating aquaporin 9.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: August 4, 2020
    Assignee: APOGLYX AB
    Inventors: Johan Evenas, Joakim Larsson, Klaus Dreisch
  • COMPOUNDS FOR MODULATING AQUAPORINS
    Publication number: 20190127360
    Abstract: The invention relates to compounds of formula (I) pharmaceutical compositions thereof and methods for modulating aquaporin 9.
    Type: Application
    Filed: April 28, 2017
    Publication date: May 2, 2019
    Applicant: APOGLYX AB
    Inventors: Johan EVENAS, Joakim LARSSON, Klaus DREISCH
  • Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes
    Patent number: 10011597
    Abstract: Disclosed are compounds, pharmaceutical compositions and methods for modulating aquaporin 9.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: July 3, 2018
    Assignee: APOGLYX AB
    Inventors: Michael Rützler, Thomas Brimert, Klaus Dreisch, Johan Evenäs, Joakim Larsson